$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
NEW YORK, NY / ACCESS Newswire / February 23, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK CITY, NY / ACCESS Newswire / February 23, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GS
GSK plc Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - GSK
10:57pm, Saturday, 22'nd Feb 2025
NEW YORK, NY / ACCESS Newswire / February 22, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK, Feb. 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts (“ADRs”) of GSK plc (NYSE: GSK) between Febr
Levi & Korsinsky Notifies Shareholders of GSK plc(GSK) of a Class Action Lawsuit and an Upcoming Deadline
10:03pm, Saturday, 22'nd Feb 2025
NEW YORK, NY / ACCESS Newswire / February 22, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
Shareholders of GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK
06:02pm, Saturday, 22'nd Feb 2025
NEW YORK, NY / ACCESS Newswire / February 22, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
A Securities Fraud Lawsuit Has Been Filed Against GSK plc And Investors With Losses Are Urged To Contact The Schall Law Firm
10:00am, Saturday, 22'nd Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the C
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE:GSK) between F
April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GSK
01:50pm, Friday, 21'st Feb 2025
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit.
GSK LAWSUIT ALERT: Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline
12:45pm, Friday, 21'st Feb 2025
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
Shareholders That Lost Money on GSK plc (GSK) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
11:45am, Friday, 21'st Feb 2025
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against GSK plc
11:00am, Friday, 21'st Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the C
Class Action Filed Against GSK plc (GSK) - April 7, 2025 Deadline to Join - Contact Levi & Korsinsky
10:30am, Friday, 21'st Feb 2025
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GS
Sign In
Buy GSK